Prosecution Insights
Last updated: April 19, 2026

Examiner: GEBRESLASSIE, WINTA

Tech Center 2600 • Art Units: 2668 2677

This examiner grants 76% of resolved cases

Performance Statistics

75.9%
Allow Rate
+13.9% vs TC avg
186
Total Applications
+24.7%
Interview Lift
887
Avg Prosecution Days
Based on 133 resolved cases, 2023–2026

Rejection Statute Breakdown

3.3%
§101 Eligibility
16.8%
§102 Novelty
66.4%
§103 Obviousness
5.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19205753 MACHINE-LEARNING-ENABLED PREDICTIVE BIOMARKER DISCOVERY AND PATIENT STRATIFICATION USING STANDARD-OF-CARE DATA Final Rejection Insitro, Inc.
19177402 MACHINE-LEARNING-ENABLED PREDICTIVE BIOMARKER DISCOVERY AND PATIENT STRATIFICATION USING STANDARD-OF-CARE DATA Final Rejection Insitro, Inc.
18164536 ENDOSCOPIC IMAGE PROCESSING DEVICE, ENDOSCOPIC IMAGE PROCESSING METHOD, ENDOSCOPIC IMAGE PROCESSING PROGRAM, AND ENDOSCOPE SYSTEM Non-Final OA FUJIFILM Corporation
18598584 Virtual color sensor for recognizing and distinguishing different-colored objects and in particular containers Non-Final OA KRONES AG
18681342 MEASURING SYSTEM Non-Final OA DAI NIPPON PRINTING CO., LTD.
18572352 COMPUTATIONAL TECHNIQUES FOR THREE-DIMENSIONAL RECONSTRUCTION AND MULTI-LABELING OF SERIALLY SECTIONED TISSUE Non-Final OA The Johns Hopkins University
18181242 MEASURING INTRAMUSCULAR FAT Non-Final OA Hologic, Inc.
17991576 DETERMINING POINT SPREAD FUNCTION FROM CONSECUTIVE IMAGES Non-Final OA Varjo Technologies Oy
18096097 MANAGEMENT DEVICE, EXAMINATION IMAGE EVALUATION METHOD, AND MEDICAL SYSTEM Final Rejection OLYMPUS CORPORATION
18609005 MAJOR ADVERSE CARDIOVASCULAR EVENT RISK PREDICTION BASED ON COMPREHENSIVE ANALYSIS OF CT CALCIUM SCORE EXAM Non-Final OA Case Western Reserve University
18443383 IMAGE PROCESSING DEVICE AND IMAGE PROCESSING METHOD Non-Final OA Keyence Corporation
17899746 Providing and Using a Monitoring Service Non-Final OA AT&T Intellectual Property I, L.P.
18562027 METHODS, SYSTEMS, AND PROGRAM PRODUCTS FOR DETECTING LESIONS IN PROSTATES USING MAGNETIC RESONANCE IMAGING (MRI) IMAGES Non-Final OA The Research Foundation for the State University of New York
18278323 DEEP LEARNING MODEL-BASED TUMOR-STROMA RATIO PREDICTION METHOD AND ANALYSIS DEVICE Final Rejection SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
18439259 SYSTEM AND METHOD OF DETERMINING AN ACCURATE ENHANCED LUND AND BROWDER CHART AND TOTAL BODY SURFACE AREA BURN SCORE Final Rejection Applied Research Associates, Inc.
18556405 QUANTIFYING THE TUMOR-IMMUNE ECOSYSTEM IN NON-SMALL CELL LUNG CANCER (NSCLC) TO IDENTIFY CLINICAL BIOMARKERS OF THERAPY RESPONSE Non-Final OA H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
17831177 PERFORMING INFERENCE USING SIMPLIFIED REPRESENTATIONS OF CONVOLUTIONAL NEURAL NETWORKS Non-Final OA VIANAI SYSTEMS, INC.
18602007 LIDAR POINT CLOUD SEGMENTATION METHOD, DEVICE, APPARATUS, AND STORAGE MEDIUM Non-Final OA THE CHINESE UNIVERSITY OF HONG KONG (SHENZHEN) FUTURE NETWORK OF INTELLIGENCE INSTITUTE
17981988 SYSTEMS AND METHODS FOR ANNOTATING TUBULAR STRUCTURES Final Rejection Shanghai United Imaging Intelligence Co., Ltd.
18684618 DEEP LEARNING-BASED ABNORMAL BEHAVIOR DETECTION SYSTEM THROUGH DEIDENTIFICATION DATA ANALYSIS Non-Final OA UNIUNI CORPORATION
18015036 METHOD AND SYSTEM FOR AUTOMATED GENERATION OF TEXT CAPTIONS FROM MEDICAL IMAGES Final Rejection Harrison-AI Pty Ltd.
18502867 EXPLAINABLE AI (XAI) PLATFORM FOR COMPUTATIONAL PATHOLOGY Non-Final OA SpIntellx, Inc.
18371979 METHOD AND DEVICE FOR DETECTING A PRESENCE OF A FLUORESCENCE PATTERN ON AN IMMUNOFLUORESCENCE IMAGE OF A BIOLOGICAL CELL SUBSTRATE Non-Final OA EUROIMMUN Medizinische Labordiagnostika AG
18263506 REPRESENTING A BIOLOGICAL IMAGE AS A GRID DATA-SET Non-Final OA CBMED GMBH CENTER FOR BIOMARKER RESEARCH IN MEDICINE
18328278 AUTOMATED SCREENING FOR DIABETIC RETINOPATHY SEVERITY USING COLOR FUNDUS IMAGE DATA Final Rejection Hoffmann La-Roche Inc.
18065582 SELECTING ANALYSIS ALGORITHMS TO USE TO GENERATE MEDICAL FINDINGS FOR MEDICAL IMAGES Final Rejection RADIOLOGY PARTNERS, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month